ABSTRACT Influenza A (H7N9) viruses have caused severe human infections and deaths every year in China since 2013. To reduce the risk of human infection and prevent a new influenza pandemic, there is a pressing need to develop safe and effective anti-H7N9 vaccines for poultry. Polyethyleneimine (PEI) is an organic polycation used extensively as a transfection reagent for decades. Although the adjuvant potential of PEI is well studied in mammals, its applicability and immune characteristics to avian species are still very rare. Here, to investigate the adjuvant activity of PEI, we analyzed the immune responses in chicken peripheral blood mononuclear cells in vitro. PEI significantly upregulated the expression of immune-related cytokines (IFN-γ, IL-2, IL-4, IL-6, IL-18, and IL-1β) and chemokines (CXCLi1, CXCLi2, MIP-1β, and MCP-3), suggesting that PEI promoted immune responses of avian cells. We also assessed the in vivo immune responses to PEI in a chicken model. After the second and third vaccinations, significantly higher IgG titers were observed in the chickens immunized with HA1-2+PEI than that of HA1-2 alone. The HA1-2+PEI group also increased percentages of CD4 + and CD8 + T cells and improved PBMC proliferation. The significantly upregulated IFN-γ and IL-4 levels of splenocytes from HA1-2+PEI vaccinated chickens further indicated that PEI promoted a Th1/Th2 mixed immune responses. This study not only demonstrates the adjuvant potential of PEI when co-administered with influenza H7N9 antigen HA1-2 in chickens, but also supports the use of PEI as a versatile systemic adjuvant platform in poultry.
INTRODUCTION
Since 2013, a total of 1,564 laboratory-confirmed cases of human infection with influenza A (H7N9) viruses, including at least 612 deaths, have been reported to World Health Organization (http://www. who.int/influenza/human animal interface/Influenza Summary IRA HA interface 10 30 2017.pdf?ua = 1). Between 2017 January 19 and February 14, a total of 304 human cases of infection with H7N9 influenza virus were reported. Compared with earlier waves of infection, this fifth wave of H7N9 influenza infection had a larger geographic spread. Currently, there is no evidence of sustained human-to-human transmission of this virus. As in previous waves, most of the cases reported in 2017 were linked to prior exposure to live C 2018 Poultry Science Association Inc. Received December 27, 2017. Accepted July 19, 2018. 1 Corresponding authors: jiao@yzu.edu.cn (XJ); zmpan@yzu.edu.cn (ZP) poultry or potentially contaminated environments. Notably, H7N9 virus causes little or no illness in poultry (http://www.who.int/influenza/human animal interface/avian influenza/riskassessment AH7N9 201702/en/), which increases the risk of human infection as well as the risk of a new influenza pandemic. Therefore, a safe and effective H7N9 influenza vaccine for poultry is desperately needed.
Compared with traditional vaccines, subunit vaccines confer equal protection and have a higher level of biosecurity as well as quicker vaccine production times . The use of hemagglutinin (HA) as a protective antigen in influenza vaccines has been well established in different animal models. Previously, we reported that HA1-2, the globular head domain of the H7N9 influenza HA expressed in Escherichia coli, was an effective antigen for use in influenza H7N9 subunit vaccines in mice (Song et al., 2015) .
Polyethyleneimine (PEI), an organic polycation, is used extensively as a gene and DNA vaccine delivery reagent. A recent study found that PEI has potent 4245 adjuvant activity for viral glycoprotein antigens, including gp140 derived from human immunodeficiency virus 1 and HA protein derived from H1N1 influenza virus (Wegmann et al., 2012; Sheppard et al., 2014) . Previously, we demonstrated that HA1-2 combined with PEI could elicit effective and HA1-2-specific humoral and cellular immune responses in a mouse model (Song et al., 2016) , and chickens vaccinated with PEIadjuvanted HA1-2 exhibited robust antibody responses leading to a significant reduction in viral loads of throat and cloaca compared to chickens receiving only HA1-2 (Song et al., 2017) . However, the cellular mechanism of adjuvant activity of PEI in poultry is not very clear, such as the activation of the avian immune cells and the immune response types (Th1 or Th2) induced by PEI co-delivered with HA1-2 antigen. In mouse models, PEI adjuvanted gp140 antigen by mucosal immunization induced a Th2 bias immune response, and a mixed Th1/Th2 type immunity was elicited when PEI administered subcutaneously (Wegmann et al., 2012; Sheppard et al., 2014) . We hypothesized that PEI might also have immune-activating activity in avian immune cells and that PEI combined with the antigen might elicit enhanced Th1/Th2 mixed immune responses in chickens.
In this study, we evaluated the adjuvant effects of PEI on peripheral blood mononuclear cells (PBMCs) from specific pathogen-free (SPF) chickens in vitro by examining the expression levels of immune response genes for cytokines and chemokines. Additionally, we immunized chickens intramuscularly with HA1-2 combined with PEI (HA1-2+PEI) to investigate the humoral and cellular immune responses and the Th1 or Th2 immune type bias, with the aim of providing basic research data for the application of PEI-based effective systemic subunit vaccine for H7N9 influenza in poultry.
MATERIALS AND METHODS

Experimental Chickens
All SPF White Leghorn chickens were purchased from the Poultry Institute, Shandong Academy of Agricultural Science, Shandong, China. All birds were housed in isolation and a pathogen-free diet and water were supplied ad libitum. All animal experiments were performed in accordance with the Committee on the Ethics of Animal Experiments of Yangzhou University (Approval ID: SYXK [Su] 2012-0029).
Vaccine Candidates Preparation
Recombinant His-tagged HA1-2 protein was expressed and purified using a His r Bind Purification Kit (Novagen, Billerica, MA) as previously described (Song et al., 2015) . Endotoxin of the resulting protein was removed using the ProteoSpin Endotoxin Removal Kit Maxi for protein and peptides (Norgen, Thorold, Ontario, Canada), and the level of residual endotoxin was measured using a chromogenic endpoint tachypleus amebocyte lysate assay kit (Chinese Horseshoe Crab Reagent Manufactory Co., Ltd., Xiamen, China) according to the manufacturer's instructions. HA1-2+PEI complexes were formed by adding the HA1-2 protein into a pre-diluted branched PEI (Sigma-Aldrich, St. Louis, MO) solution. Moreover, purified HA1-2 protein was mixed thoroughly with an equal volume of alum adjuvant (Thermo Fisher Scientific, Rockford, IL) before each immunization.
Chicken PBMCs Preparation and Stimulation
The PBMCs were obtained from peripheral blood of SPF White Leghorn chickens using Ficoll-Hypaque (Sigma-Aldrich) separation liquid, and the cells were suspended and cultured in complete Roswell Park Memorial Institute 1640 medium plus 10% fetal bovine serum and 1% penicillin-streptomycin/L-glutamine (Gibco, Carlsbad, CA). PBMCs were cultured in 24-well microtiter plates at a seeding density of 2 × 10 6 cells/mL, and the cells were treated with HA1-2 (3 μg/mL) or HA1-2+PEI (3 μg/mL HA1-2 combined with 20 μg/mL PEI). All cells were harvested after 12 h for RNA extraction, and expression levels of cytokines and chemokines were evaluated by quantitative realtime PCR (qRT-PCR).
Total RNA Isolation and qRT-PCR for Cytokines and Chemokines
Total RNA of cells was extracted using the RNeasy Plus Mini kit (Qiagen, Hilden, Germany), and the reverse transcription of the RNA samples was performed using a PrimeScrip RT reagent kit with gDNA eraser (TaKaRa, Dalian, China), each according to the manufacturer's instructions. The mRNA levels of cytokines and chemokines were determined using an ABI 7500 instrument (Applied Biosystems, Foster, CA) with designed primers shown in Table 1 . Amplification was performed in a 20 μL reaction mixture containing 2 μL of diluted cDNA, 10 μL of 2 × SYBR Premix Ex Taq II (Takara), and 0.6 μL of forward and reverse primers. The data were reported as values that were normalized to the housekeeping gene β-actin and calculated as 2 −ΔΔCT (n-fold change compared with the control group).
Chicken Immunization and Sampling
SPF chickens at 2-week-old were randomly split into 4 groups (n = 8) and immunized intramuscularly either with HA1-2 (10 μg), HA1-2+PEI (10 μg HA1-2 combined with 20 μg PEI), phosphate-buffered saline (PBS) as the negative control, and HA1-2+Alum mixture (containing 10 μg HA1-2) as the positive control. These chickens were vaccinated in the breast muscle 3 times on days 0, 14, and 28 in a volume of 200 μL/dose.
All chickens were bled from the wing vein at 12 d after the second and third vaccination. Serum samples were prepared for analysis of the HA1-2-specific IgG titers by enzyme-linked immunosorbent assay (ELISA). Two weeks after the third vaccination, all chickens were sacrificed, and PBMCs were prepared for detecting the cell proliferation and T lymphocyte subset (CD4 + and CD8 + ) activation. Splenocytes were prepared for the Th1-and Th2-related cytokine expression assays.
Enzyme-Linked Immunosorbent Assay
Serum titers of HA1-2-specific IgG titers were determined by ELISA as previously described (Song et al., 2015) . Briefly, 96-well ELISA plates were coated overnight with glutathione S-transferase-tagged HA1-2 antigen (1.5 μg/mL) in carbonate buffer (50 mM, pH 9.6) at 4
• C. After washing and blocking, samples were added at an initial dilution of 1:100 with a 2-fold dilution series in dilution buffer and incubation for 2 h at 37
• C. Then, HA1-2-specific antibodies were detected using anti-chicken IgG (IgY) conjugated to HRP (1:10,000 dilution) (Sigma-Aldrich) for 1 h at 37
• C, after which 3, 3 , 5, 5 -tetramethybenzidine was added to each well to evaluate the enzymatic activity. The reaction was stopped with 2 M H 2 SO 4 , and the ODs were read at 450 nm using an ELISA reader (Bio-Tek, Winooski, VT).
FACS Analysis
Two weeks after the last vaccination, PBMCs were obtained from each group of chickens as described above, and the cells (2 × 10 6 cells/mL) were resuspended in PBS for CD4 + and CD8 + T-cell popula- 
Cell Proliferation of PBMCs
PBMCs were obtained from each vaccinated chicken after the last immunization as described above, and the cell proliferation assay of PBMCs (2 × 10 5 cells/well) pre-treated with 10 μg/mL of ConA was evaluated using a commercially available ELISA-BrdU Kit (Roche Diagnostics, Tokyo, Japan) according to the manufacturer's instruction.
Splenocyte IFN-γ and IL-4 Expression
Splenic lymphocytes were obtained from the spleens of immunized chickens using 1077 Histopaque (SigmaAldrich) as previously described (Song et al., 2017) . The cells were cultured in 24-well microtiter plates at a seeding density of 2 × 10 6 cells/mL and treated with 10 μg/mL of HA1-2 for 5 h. The mRNA was extracted as described above, and the expression levels of IFN-γ and IL-4 were evaluated by qRT-PCR.
Statistical Analysis
Data are expressed as the mean ± SEM. Serum titers of HA1-2-specific IgG were analyzed using log10 transformed data. Statistical significance between 2 groups was analyzed using an unpaired Student's t-test with GraphPad Software 5.0 (San Diego), and P < 0.05 was considered statistically significant. PBMCs isolated from non-immunized SPF chickens were treated with HA1-2 or HA1-2+PEI for 12 h in vitro. The mRNA levels of cytokines (A) and chemokines (B) in PBMCs were measured by qRT-PCR, and the fold change refers to the data being compared to control group. Data are presented as mean ± SEM.
* P < 0.05, * * P < 0.01.
RESULTS
PEI Promotes the Immune Activation of Chicken PBMCs in Vitro
To evaluate the immune activation induced by PEI, PBMCs were isolated from chickens and treated with HA1-2 alone or in combination with PEI, and the mRNA levels of immune response-associated cytokines and chemokines were detected by qRT-PCR. A quantitative analysis of the cytokine expression showed significant increases for both Th1 (IFN-γ and IL-2) (15.9-and 6.9-fold, respectively, P < 0.05) and Th2 (IL-4, IL-6, and IL-18) (9.2-, 10.9-, and 2.8-fold, respectively, P < 0.05) cytokines in HA1-2+PEI-treated cells compared with the HA1-2-treated control ( Figure 1A) . We also assessed proinflammatory IL-1β and several types of chemokines in these cells. The results showed that the fold changes of mRNA expression levels of IL-1β (6.9-fold, P < 0.01), CXCLi1 (30.0-fold, P < 0.05), CXCLi2 (6.1-fold, P < 0.01), MIP-1β (5.6-fold, P < 0.05), and MCP-3 (9.8-fold, P < 0.05) were also significantly increased in the HA1-2+PEI-treated group compared with those in the HA1-2-treated group ( Figure 1B) .
PEI Enhances the Humoral Immune Responses in Chickens
To determine the efficacy of the HA1-2+PEI subunit vaccine on humoral immune responses in SPF chickens, serum samples were collected on day 12 after the second and third immunizations for HA1-2-specific IgG anti- Chickens were bled 12 d after the second and third immunizations, and the serum IgG titers were measured by ELISA. Data are presented as mean ± SEM.
* P < 0.05, * * P < 0.01. body measurement. The PEI-adjuvanted group elicited significantly higher IgG antibody levels after both the second and third vaccinations (3,733, P < 0.01 and 14,080, P < 0.01, respectively) than those of the HA1-2 vaccinated group (183 and 400, respectively) ( Figure 2) . Moreover, the serum IgG titer after the third immunization (10 4 level) was significantly increased compared with that after the second immunization (10 3 level) in both PEI and alum adjuvanted group (both P < 0.01), and no significant difference was observed between the 2 groups.
PEI Improves Cellular Immune Responses in Chickens
The cellular immune responses were monitored by flow cytometry and cell proliferation tests of PBMCs isolated from chickens at 2 weeks after the third immunization. The T lymphocyte activation was evaluated by the percentages of T-cell subsets (CD4 + and CD8 + ) analyzed by FACS. The results showed that the percentages of CD4 + T cells (CD3 + CD4 + ) and CD8 + T cells (CD3 + CD8 + ) in the PBMC populations were significantly increased in the chickens vaccinated with HA1-2+PEI (59.4%, P < 0.05, and 24.8%, P < 0.05, respectively) compared with those in chickens vaccinated with HA1-2 only (46.9% and 19.25%, respectively), and only CD4 + T-cell activation in alum control group (66.5%, P < 0.05) was significantly increased than in HA1-2 group ( Figure 3A and B) . These data suggest that PEI promoted the activation of both CD4 + and CD8 + T cells in PBMCs. To further determine the cellular immune responses induced by HA1-2+PEI, the stimulation index was used to evaluate the proliferation ability of PBMCs. As shown in Figure 3C , the proliferative index of cells from HA1-2+PEI vaccinated group (2.8 on average, P < 0.05) was significantly higher than that in HA1-2 vaccinated group (1.5 on average). Together, these results suggest that the PEI adjuvant plays an important role in the stimulation of lymphocyte proliferation and activation in vaccinated chickens.
PEI Promotes Th1/Th2 Mixed Immune Responses
To further evaluate the influence of the PEI adjuvant on the immune responses types, we detected the expression levels of IFN-γ (a Th1-type cytokine) and IL-4 (a Th2-type cytokine) in splenic lymphocytes of immunized SPF chickens. The IFN-γ and IL-4 levels in splenocytes of chickens vaccinated with HA1-2+PEI were significantly higher (2.9-fold, P < 0.05, and 3.3-fold, P < 0.05, respectively) than that of chickens vaccinated with HA1-2 in the absence of an adjuvant (1.1-fold and 1.2-fold, respectively) (Figure 4 ). This result was consistent with the cytokine expression profile of PBMCs described above. Meanwhile, the results also showed that only IL-4 expression level in alum control group significantly increased (4.1-fold, P < 0.05) than that in HA1-2 vaccinated group (Figure 4) . . Splenocyte IL-4 and IFN-γ expression levels. Splenocytes were prepared from chickens at 14 d after the last vaccination and were treated with 10 μg/mL of HA1-2 in triplicate for 5 h. The mRNA levels of IL-4 and IFN-γ were detected by qRT-PCR, and the fold change refers to the data being compared to PBS control group. Data are presented as mean ± SEM.
* P < 0.05.
DISCUSSION
The influenza A (H7N9) viruses emerged in the spring of 2013 in China had caused severe human infections and deaths (Gao et al., 2013) . However, they were nonlethal in poultry. It is worth noting that certain low pathogenic avian influenza viruses can mutate to highly pathogenic viruses when they circulate in domestic poultry, causing destructive poultry diseases and severe economic damage (Shi et al., 2017) . Thus, the elimination of low-pathogenic avian H7N9 influenza virus in poultry becomes even more important.
The cellular mechanisms of how the PEI adjuvant affects innate immune responses in mammals have been well established by previous studies (Wegmann et al., 2012) . However, there have been few related studies on avian cells. Activation of the innate immune system is characterized by the production of inflammatory cytokines. Therefore, to characterize early events in the immune response to PEI, we initially used an in vitro avian cell model. The results showed that HA1-2 combined with PEI significantly upregulated the expression of immune-related cytokines and chemokines by PBMCs from SPF chickens when compared with the levels in chicken cells treated with HA1-2 alone. Of the cytokines that have been sequenced in chickens, IL-1β, IL-6, and IFN-γ each possess a biological activity that is similar to that of these cytokines in mammals (Digby and Lowenthal, 1995; York et al., 1996; Kaiser and Mariani, 1999) . The induction of chemokines is essential for an efficient induction of the immune response (Gouwy et al., 2005) . Overall, PEI merits further investigation as a vaccine adjuvant for use in poultry.
We next investigated whether PEI could induce an adaptive immunity, particularly the cellular immune responses in chickens. Previous studies showed that mice vaccinated intraperitoneally with PEI-based DNA complexes induced significantly higher total IgG antibody responses compared to other DNA complex (Al-Deen et al., 2017) . Moreover, PEI administered intranasally with HA1-2 of H7N9 influenza enhanced antigen-specific serum IgG production (Song et al., 2017) . Notably in this study, higher IgG titers were observed in chickens immunized intramuscularly with HA1-2+PEI after the second and third immunizations.
Cytokines play an important role in modulating immune responses (Kim et al., 1999) . IL-4 is often measured as a standard Th2 marker, while IFN-γ is a common Th1 marker (Tritel et al., 2003) . To examine the antigen-specific IFN-γ and IL-4 levels in response to vaccination, we used qRT-PCR to measure the cytokine expression of splenocytes from the immunized chickens. Our data showed that both IFN-γ and IL-4 levels were significantly higher in splenocytes from the HA1-2+PEI immunized group than that of the HA1-2 group, suggesting that PEI can elicit balanced Th1 and Th2 immune responses, which was superior to alum eliciting Th2-bias immune responses. These results are consistent with a recent study reporting that IL-4 and IFN-γ levels in the supernatants from ex vivo splenocytes culture were enhanced by the PEI formulated DNA vaccine (Cherif et al., 2014) .
We measured proliferation and T-cell populations in PBMCs to evaluate the cellular immune responses induced by using PEI as an adjuvant. Since the T-cell response plays a major role in eliminating the virus infection, we analyzed CD4 + and CD8 + T-cell activation in immunized chickens. We found that PEI significantly increased the percentage of CD4 + and CD8 + T cells in PBMCs and improved their cell proliferation capacity, which was consistent with mouse model results that vaccination with H9N2 influenza whole inactivated virus combined with PEI (Qin et al., 2015) and PEI formulated with a reporter plasmid (Regnström et al., 2003) greatly increased the activation of both CD4 + and CD8 + T cells. This finding was also in accord with our in vitro results of Th1 (IFN-γ and IL-2) and Th2 (IL-4 and IL-6) cytokine expression in PBMCs and the in vivo results of IFN-γ and IL-4 expression in splenocytes.
Future work should investigate the effects of mixing PEI with other adjuvants. Since PEI is a soluble polymer, co-formulation with an antigen and other adjuvants only requires simple mixing, which avoids the complicated procedures that are required for oil-water emulsions. The use of TLR ligands as adjuvants has been associated with systemic adverse effects (Lipford et al., 1997; Nordly et al., 2011) . PEI increased the production of inflammatory cytokines and chemokines in this study, which is the foundation of its adjuvanticity. However, there is limited publications related to the effect of PEI on immunity, a further understanding of its immune mechanism, especially the relationship with the cytotoxicity, is of great significance. Notably, the immune responses in the early stage induced by PEI in chickens are still worthy of investigation as the majority of birds raised in the industry are broilers. Besides, the immunizing doses and immunizing times are also needed to be optimized, so that it may be used more widely.
In summary, PEI could induce strong innate immune responses in the PBMCs of chickens, including the expression of inflammatory cytokines (IL-1β, IL-18, IL-6, and IFN-γ) and chemokines (CXCLi1, CXCLi2, MIP-1β, and MCP-3). Chickens immunized intramuscularly with HA1-2+PEI had significantly enhanced humoral and cellular immune responses compared with chickens immunized with HA1-2 alone. Together, these data suggest that PEI has potential adjuvant capacity when it is combined with influenza H7N9 antigen HA1-2, which could act as a versatile systemic adjuvant platform in poultry.
